Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms

• Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

  Business - MarketWatch - November 4

• Viking Therapeutics is more than just a weight-loss stock, and that’s drawing cheers

  Business - MarketWatch - 19 hours ago

• Amgen says no concerns around weight loss drug’s bone density data after stock falls

  Business - CNBC - November 13

• RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

  Business - MarketWatch - 4 days ago
• 

  Nurse’s death linked to approved weight-loss drug

  Top stories - BBC News - November 8

• Bristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial

  Business - MarketWatch - November 11

More from MarketWatch

• Inflation fears are back ahead of Trump’s second term. Why investors burned before aren’t eager to hedge against it.

  Business - MarketWatch - 10 minutes ago

• Deere’s earnings tumble but still blow past estimates as company offers soft guidance on weak demand

  Business - MarketWatch - 20 minutes ago

• Beware of the ‘Ponzi funds’ that are hiding in plain sight, says strategist

  Business - MarketWatch - 33 minutes ago

• I’m a 73-year-old widower who wants to take 6% out of my 401(k) instead of 4%. Can I afford it?

  Business - MarketWatch - 1 hour ago

• ‘God works in mysterious ways’: I became a Nvidia millionaire playing ‘World of Warcraft.’ Am I smart — or just lucky?

  Business - MarketWatch - 1 hour ago